Orphanet: Pesquisa por doença/gene
x

Pesquisar um projeto de investigação

* (*) campo(s) de preenchimento obrigatório

44 Resultado(s)

Ordenados por

Financiado por um membro do IRDiRC =

Projetos de investigação

FRANCA

PROVENCE-ALPES-COTE D'AZUR
NICE

Immuno-histochemical and molecular diagnosis of epidermolysis bullosa (COL17A1, PLEC1, LAMA3, LAMB3, LAMC2, COL7A1, ITGB4 and ITGA6 genes)
Faculté de médecine de Nice Sophia-Antipolis
Biologie et physiopathologie cutanée : expression génique, signalisation et thérapie

ITALIA

PIEMONTE
TORINO

Financiado por um membro do IRDiRCRole of PI3K/AKT in stratified epithelia stem cell
Università degli Studi di Torino
Centro di Biotecnologie Molecolari

SUECIA

Region Uppsala
UPPSALA

Studies on the etiology and therapy of monogenetic dermatoses affecting the skin barrier
Akademiska Sjukhuset
Department of Medical Sciences, Dermatology and Venereology

ALEMANHA

Baden-Württemberg
FREIBURG

ALEMANHA

Baden-Württemberg
FREIBURG

Financiado por um membro do IRDiRCMuTaEB : Mutation-targeted gene and pharmacological therapies for dystrophic and junctional Epidermolysis Bullosa (partner no 1)
Universitäts-Klinik für Dermatologie und Venerologie
Epidermolysis bullosa-Zentrum

ALEMANHA

Schleswig-Holstein
LÜBECK

Cutaneous complement C3 as key driver of pemphigoid disease pathogenesis (KFO 303: Pemphigoid Diseases - Molecular Pathways and their Therapeutic Potential)
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Klinik für Dermatologie, Allergologie und Venerologie

CANADA

Québec
QUÉBEC

Gene therapy for recessive dystrophic epidermolysis bullosa
Centre de recherche - Hôtel-Dieu de Québec
Centre de recherche du CHU de Québec/Université Laval

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCProtein trafficking in the endosomal-lysosomal system
Institution: Information not provided - US

FRANCA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCA

BOURGOGNE-FRANCHE-COMTE
DIJON

Molecular diagnosis of poikiloderma with neutropenia (C16ORF57 gene sequencing)
CHU de Dijon - Plateau technique de Biologie
Laboratoire de génétique chromosomique et moléculaire

FRANCA

ILE-DE-FRANCE
PARIS

Constitutive hematologic diseases: clinical and therapeutic research, molecular biology
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Service d'hématologie pédiatrique

FRANCA

ILE-DE-FRANCE
PARIS

Physio-pathological study of generalized pustular psoriasis: genetic and molecular characterization
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Service de dermatologie

JAPAO

JAPAN
AICHI

Financiado por um membro do IRDiRCDevelopment of innovative drug for generalized pustular psoriasis as deficiency of IL-36 receptor antagonist
Fujita Health University School of Medicine
Department of Dermatology

JAPAO

JAPAN
HOKKAIDO

Financiado por um membro do IRDiRCA strategy to optimize treatment options for epidermolysis bullosa
Hokkaido University Hospital
Department of Dermatology

REINO UNIDO

Tayside
DUNDEE

ALEMANHA

Niedersachsen
GÖTTINGEN

ALEMANHA

Schleswig-Holstein
LÜBECK

KFO 303: Pemphigoid Diseases - Molecular Pathways and their Therapeutic Potential : The skin microbiome modulating Pemphigoid Diseases - DE
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Lübecker Institut für Experimentelle Dermatologie

ESPANHA

Madrid
LEGANÉS

MULTITEREB: Development and pre-clinical evaluation of advanced multimodal therapies for recessive dystrophic epidermolysis bullosa
Universidad Carlos III de Madrid - Campus de Leganés
Grupo de Ingeniería de Tejidos y Medicina regenerativa

ESPANHA

Madrid
MADRID

Financiado por um membro do IRDiRCPrecision gene therapy for rare dermo-epidermal fragility diseases
CIEMAT - Centro de Investigaciones Energéticas Medioambientales y Tecnológicas
División de biomedicina epitelial

PAISES BAIXOS

Groningen
GRONINGEN

Financiado por um membro do IRDiRCGenetic therapy through exon-skipping for dystrophic epidermolysis bullosa
UMCG - Universitair Medisch Centrum Groningen
Afdeling Genetica

AUSTRIA

WIEN
WIEN

Molecular mechanisms of plectin-related muscular dystrophy
Medizinische Universität Wien
Zentrum für Anatomie und Zellbiologie

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

ABHD5 and PNPLA1 Function in the Skin
Institution: Information not provided - AT

ALEMANHA

Baden-Württemberg
FREIBURG

Financiado por um membro do IRDiRCKLKIN : Netherton Syndrome: From mechanisms to therapeutics - DE (partner no 3)
Albert-Ludwigs-Universität Freiburg
Institut für Molekulare Medizin und Zellforschung

ALEMANHA

Baden-Württemberg
FREIBURG

Financiado por um membro do IRDiRCPropekal5 : Tracing the untackled facets of Peeling Skin Disease-Targeting epidermal proteolysis for treatment - DE (partner no 1)
Albert-Ludwigs-Universität Freiburg
Institut für Molekulare Medizin und Zellforschung

ALEMANHA

Nordrhein-Westfalen
BONN

Financiado por um membro do IRDiRCPropekal5 : Tracing the untackled facets of Peeling Skin Disease-Targeting epidermal proteolysis for treatment - DE (partner no 1)
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany

ITALIA

LAZIO
ROMA

Study of inherited skin disorders: molecular pathogenesis, diagnosis and genotype-phenotype correlation
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
U.O.C. di Dermatologia

ITALIA

LAZIO
ROMA

Netherton syndrome: from disease pathogenesis to improved diagnosis and patient care
Istituto Dermopatico dell'Immacolata - IRCCS
Laboratorio di Biologia Molecolare e Cellulare

Projetos de investigação multicêntricos